Literature DB >> 8752913

Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.

M P Schutze-Redelmeier1, H Gournier, F Garcia-Pons, M Moussa, A H Joliot, M Volovitch, A Prochiantz, F A Lemonnier.   

Abstract

The homeodomain of the Antennapedia molecule (AntpHD) spontaneously crosses cellular membranes and can be used to deliver up to 50 additional amino acids to the cytoplasm. We exploited this approach to deliver antigenic peptides to the MHC class I processing and presentation pathway. AntpHD-based fusion peptides expressing the 170-179 HLA-Cw3 CTL epitope (pCw3) were produced in bacteria. Incubation of these fusion peptides with H-2d target cells resulted in efficient delivery to the cytosol as indicated by protease resistance and confocal microscopy. Moreover, this introduction of an exogenous Ag resulted in sensitization of the cell to lysis by a CTL clone specific for the 170-179 HLA-Cw3-derived peptide. Sensitivity of the Ag processing to brefeldin A but not to chloroquine is consistent with the delivery of AntpHD fusion peptides to the conventional class I-associated processing pathway. Immunization of DBA/2 (H-2d) mice with AntpHD pCw3 fusion peptide in the presence of SDS primed H-2Kd-restricted HLA-Cw3-specific CTL. Similar results were obtained with AntpHD fusion peptides expressing the 147-156 influenza nucleoprotein peptide. The strategy outlined in this paper provides a new approach for introducing molecules into the MHC class I Ag-presenting pathway. This approach has clear relevance to the design of synthetic peptide-based vaccines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.

Authors:  Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2003-12-02       Impact factor: 4.599

2.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

3.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

4.  Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules.

Authors:  A Avrameas; T Ternynck; F Nato; G Buttin; S Avrameas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 5.  Anti-cancer therapies that utilize cell penetrating peptides.

Authors:  Benjamin G Bitler; Joyce A Schroeder
Journal:  Recent Pat Anticancer Drug Discov       Date:  2010-06       Impact factor: 4.169

Review 6.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

7.  Anti-HBV effect of TAT- HBV targeted ribonuclease.

Authors:  Jin Ding; Jun Liu; Cai-Fang Xue; Wei-Dong Gong; Ying-Hui Li; Ya Zhao
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Suppression of gene expression by a cell-permeable Tet repressor.

Authors:  Alison Mortlock; Walter Low; Andrea Crisanti
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

9.  Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.

Authors:  Salvatore Valiante; Annarita Falanga; Luisa Cigliano; Giuseppina Iachetta; Rosa Anna Busiello; Valeria La Marca; Massimiliano Galdiero; Assunta Lombardi; Stefania Galdiero
Journal:  Int J Nanomedicine       Date:  2015-03-10

Review 10.  Suppression of TLR signaling by targeting TIR domain-containing proteins.

Authors:  Ota Fekonja; Monika Avbelj; Roman Jerala
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.